Corticosteroids and Rashes: A Comprehensive Review

Shravan Kumar Dholi

Department of Pharm. D And Pharm D. (PB), Vaageswari College of Pharmacy, Karimnagar Telangana – 505527, India.

D. Ruchitha Reddy *

Vaageswari College of Pharmacy, Karimnagar, Telangana – 505527, India.

*Author to whom correspondence should be addressed.


Corticosteroids are the class of medications that are widely used to treat a variety of inflammatory conditions. However, they can also a number of side effects, including rashes. Corticosteroids induces rashes can range in severity from mild to severe can occur on any part of the body. The mechanism by which corticosteroids cause rashes are not fully understood, but they are thought to involve a combination of factor, including immunosuppressant and skin atrophy. A number of risk factor for developing a corticosteroids induced rash have been identified, including the type and potency of corticosteroids used, the duration of use, and the area of application. The management of corticosteroids induces rashes depends on the type of rash and its severity. Mild cases can often be managed by discontinuing the corticosteroid and using a moisturizer. More severe cases may require treatment with prescription medication, such as topical calcineurin inhibitors or pimecrolimus. The best way to prevent corticosteroids induced rashes is to use corticosteroids as direct by the doctor. This includes using the low potential corticosteroids that is effective for your condition and using the corticosteroids for the shortest period of time necessary.

Keywords: Corticosteroids, rashes, immunosuppression, skin atrophy, risk factors, management

How to Cite

Dholi, S. K., & Reddy , D. R. (2024). Corticosteroids and Rashes: A Comprehensive Review. Asian Journal of Research in Nephrology, 7(1), 45–48. Retrieved from


Download data is not yet available.


Cutaneous adverse effects of corticosteroids: A comprehensive review. J Am Acaddermatol. 2013;69 (6):1017-29.

Corticosteroids and the skin: A review of adverse effects and management. Dermatolclin. 2020;38(1):1-11.

Corticosteroids and the risk of skin infection. Dermatolther. 2020;33(2): e13450.

Topical corticosteroid-induced skin atrophy: A review. J Am Acaddermatol. 2013;69(6):1017-29.

Diagnosis and management of topical corticosteroid- induced adverse effects. J Eur Acad dermatol venereol. 2022;36(4): 447-457.

Perioral dermatitis: A comprehensive review. J Am Acaddermatol. 2007;57(2): 14960.

Perioral dermatitis: A comprehensive review. J Am Acaddermatol. 2007;57(2): 14960.

Acneiform eruption secondary to topical corticosteroid use. Dermatol Clin. 2022; 40(1):131-140.

Striae distensae (Striae atrophicae): A comprehensive review. J Am Acaddermatol. 2007;57(1):1-10.

Impaired wound healing associated with corticosteroid use. J Am Acaddermatol. 2000;43(6):1017- 29.

Corticosteroids and the risk of cutaneous infections. J Am Acad Dermatol. 2007; 57(1):1-10.

Allergic contact dermatitis to corticosteroids. Dermatol Clin. 2016;34(1): 105-119.

Topical corticosteroid use and the risk of skin atrophy: A systematic review and meta- analysis. J Am Acaddermatol. 2015; 73(5):778-86.

Corticosteroid-induced rosacea-like dermatitis: A review of the literature. J Dermatol. 2021;48(7): 836-842.